resveratrol has been researched along with Retinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, DH; Albert, DM; Antczak, C; Champ, KG; Decarlo, D; Djaballah, H; Francis, JH; Mahida, JP; Marr, B; Polans, AS | 1 |
| Albert, DM; Darjatmoko, SR; Mohiuddin, A; Polans, AS; Sareen, D; Takach, JC; van Ginkel, PR | 1 |
2 other study(ies) available for resveratrol and Retinoblastoma
| Article | Year |
|---|---|
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Reproducibility of Results; Resveratrol; Retinal Neoplasms; Retinoblastoma; Small Molecule Libraries; Stilbenes | 2013 |
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Cycle; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Membrane Potentials; Mitochondria; Quinone Reductases; Resveratrol; Retinal Neoplasms; Retinoblastoma; Ribonucleotide Reductases; RNA, Messenger; Stilbenes; Time Factors; Tumor Cells, Cultured | 2006 |